This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
Blood samples were collected from 114 healthcare workers who received Covaxin in Chennai from February to May 2021
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
To prevent the state from facing a shortage of medical oxygen and to bolster the existing infrastructure, the SRAM & MRAM group is actively helping the state government to set up oxygen plants in multiple cities
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
The module offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides
XELJANZ is the first and only Janus kinase (JAK) inhibitor approved in Europe for the treatment of polyarticular JIA and juvenile PsA and has received regulatory approval in four indications in the European Union, the most of any JAK inhibitor
Enoxaparin Sodium Injection, USP is used for prophylaxis of Deep Vein Thrombosis (DVT) in patients undergoing abdominal, hip or knee replacement surgery, and also for the treatment of acute DVT
Subscribe To Our Newsletter & Stay Updated
